Showing results (31-40 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 21, 2022
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB): A Systematic Review and Delphi Consensus StatementEsther N Pijnappel, J Annelie Suurmeijer, Bas Groot Koerkamp, et al.
JAMA Oncology|March 17, 2022
Risk of Colorectal Cancer Associated With Lifetime Excess WeightXiangwei Li, Lina Jansen, Jenny Chang-Claude, et al.
JAMA Oncology|February 17, 2022
Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical TrialGelareh Sadigh, Robert J Gray, Joseph A Sparano, et al.
JAMA Oncology|March 31, 2022
Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer DiagnosisJulie Hallet, Rinku Sutradhar, Elie Isenberg-Grzeda, et al.
JAMA Oncology|January 27, 2022
Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal MetastasesRoman O Kowalchuk, Benjamin A Johnson-Tesch, Joseph T Marion, et al.
JAMA Oncology|January 27, 2022
Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic LeukemiaShawn H R Lee, Federico Antillon-Klussmann, Deqing Pei, et al.
JAMA Oncology|October 11, 2019
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical TrialDavid H Ilson, Josep Tabernero, Aliaksandr Prokharau, et al.
JAMA Oncology|September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy TrialAndrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
JAMA Oncology|May 3, 2019
Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing RadiotherapySubha Perni, Michael K Rooney, David P Horowitz, et al.
JAMA Oncology|October 18, 2019
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJeanne Tie, Joshua D Cohen, Yuxuan Wang, et al.
Pageof 161